Federal Register / Vol. 74, No. 116 / Thursday, June 18, 2009 / Notices 28939 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Number 

of respondents 

Number of responses per 

respondent 

Average burden per response (in 

hours) 

Total burden 

(in hours) 

Labs ................................................................................................................. 660 2 10/60 220 

Labs ................................................................................................................. 330 1 30/60 165 

Total .......................................................................................................... ........................ ........................ ........................ 385 

Dated: June 11, 2009. 

Maryam I. Daneshvar, 

Reports Clearance Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. E9–14312 Filed 6–17–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60 Day-09–0600] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. 

Alternatively, to obtain a copy of the 

data collection plans and instrument, 

call 404–639–5960 and send comments 

to Maryam I. Daneshvar, CDC Reports 

Clearance Officer, 1600 Clifton Road, 

NE., MS–D74, Atlanta, Georgia 30333; 

comments may also be sent by e-mail to 

omb@cdc.gov. 

Comments are invited on (a) whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have a 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarify of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of information technology. Written 

comments should be received within 60 

days of this notice. 

Proposed Project 

Model Performance Evaluation 

Program for Mycobacterium tuberculosis 

and Non-tuberculous Mycobacterium 

Drug Susceptibility Testing (OMB 

Control No. 0920–0600, expiration date 

03/31/2010)—Revision—National 

Center for Preparedness, Detection, and 

Control of Infectious Diseases 

(NCPDCID), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

As part of the continuing effort to 

support both domestic and global public 

health objectives for treatment of 

tuberculosis (TB), prevention of multidrug resistance, and surveillance 

programs, CDC is requesting approval 

from the Office of Management and 

Budget to continue data collection from 

participants in the Model Performance 

Evaluation Program for Mycobacterium 

tuberculosis and Non-tuberculous 

Mycobacterium Drug Susceptibility 

Testing. This request includes changes 

to the Results Form and re-introduction 

of the Laboratory Practices 

Questionnaire. 

While the overall number of cases of 

TB in the U.S. has decreased, rates still 

remain high among foreign-born 

persons, prisoners, homeless 

populations, and individuals infected 

with HIV in major metropolitan areas. 

The rate of TB cases detected in foreignborn persons has been reported to be 

more than nine times higher than the 

rate among the U.S. born population. 

CDC’s goal to eliminate TB will be 

virtually impossible without 

considerable effort in assisting heavy 

disease burden countries in the 

reduction of tuberculosis. The Model 

Performance Evaluation Program for 

Mycobacterium tuberculosis and Nontuberculous Mycobacterium Drug 

Susceptibility Testing program supports 

this role by monitoring and evaluating 

the level of performance and practices 

among national and international 

laboratories performing M. tuberculosis 

susceptibility testing. Participation in 

this program is one way laboratories can 

ensure high-quality laboratory testing, 

resulting in accurate and reliable testing 

results. 

By providing an evaluation program 

to assess the ability of the laboratories 

to test for drug resistant M. tuberculosis 

and selected strains of Non-tuberculous 

Mycobacteria (NTM), laboratories also 

have a self-assessment tool to aid in 

optimizing their skills in susceptibility 

testing. The information obtained from 

laboratories on susceptibility testing 

practices and procedures is used to 

establish variables related to good 

performance, assessing training needs, 

and aid with the development of 

practice standards. 

Participants in this program include 

domestic clinical and public health 

laboratories and international 

laboratories. Data collection from 

domestic laboratory participants occurs 

twice per year. Data collection from 

international laboratories is limited to 

those that have public health 

responsibilities for tuberculosis drug 

susceptibility testing and have obtained 

approval to participate by their national 

tuberculosis program. The data 

collected in this program will include 

the susceptibility test results of primary 

and secondary drugs, drug 

concentrations, and test methods 

performed by laboratories on a set of 

performance evaluation (PE) samples. 

The PE samples are sent to participants 

twice a year. Participants also report 

demographic data such as laboratory 

type and the number of tests performed 

annually. Participants report this data 

every two years. The burden for the 

Laboratory Practices Questionnaire has 

been adjusted for the average per year, 

since responses are received every other 

year. 

There is no cost to respondents to 

participate other than their time. 

28940 Federal Register / Vol. 74, No. 116 / Thursday, June 18, 2009 / Notices 

ESTIMATE OF ANNUALIZED BURDEN HOURS

Form Respondents Number 

of respondents 

Number of 

responses per 

respondent 

Average 

burden 

per response 

(in hours) 

Total burden 

(in hours) 

Susceptibility Testing Results Form ................................. Labs .................. 262 2 30/60 262 

Laboratory Practices Questionnaire ................................. Labs .................. 132 1 30/60 66 

Total ........................................................................... ........................... ........................ ........................ ........................ 328 

Dated: June 11, 2009. 

Maryam I. Daneshvar, 

Reports Clearance Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. E9–14313 Filed 6–17–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Delegation of Authority 

Notice is hereby given that I have 

delegated to the Administrator, 

Substance Abuse and Mental Health 

Services Administration (SAMHSA), 

with authority to redelegate, the 

authorities vested in the Secretary of 

Health and Human Services under 

section 3990 of the Public Health 

Service Act (42 U.S.C. 280g–3), as 

amended hereafter, insofar as these 

authorities pertain to the functions 

assigned to SAMHSA. 

These authorities shall be exercised 

under the Department’s Policy on 

regulations and the existing delegation 

of authority to approve and issue 

regulations. 

In addition, I have affirmed and 

ratified any actions taken by the 

SAMHSA Administrator or by any other 

SAMHSA officials, which, in effect, 

involved the exercise of this authority 

prior to the effective date of this 

delegation. 

This delegation is effective upon date 

of signature. 

Dated: June 5, 2009. 

Kathleen Sebelius, 

Secretary. 

[FR Doc. E9–14219 Filed 6–17–09; 8:45 am] 

BILLING CODE 4160–01–M 

DEPARTMENT OF HOMELAND 

SECURITY 

[Docket No. DHS–2009–0086] 

Science and Technology (S&T) 

Directorate; Submission for Review; 

Information Collection Request for the 

DHS S&T SAFETY Act Program 

AGENCY: Science and Technology 

Directorate, DHS. 

ACTION: 60-day Notice and request for 

comment. 

SUMMARY: The Department of Homeland 

Security (DHS) invites the general 

public to comment on the following 

data collection forms for the DHS 

Science and Technology Directorate’s 

Support Anti-Terrorism by Fostering 

Effective Technologies (SAFETY) Act 

Program: Registration of a Seller of an 

Anti-Terrorism Technology (DHS Form 

10010), Request for a Pre-Application 

Consultation (DHS Form 10009), Notice 

of License of Qualified Anti-Terrorism 

Technology (DHS Form 10003), 

Application for Modification of 

SAFETY Act Benefits (DHS Form 

10002), Request for Transfer of SAFETY 

Act Benefits (DHS Form 10001), 

Application for SAFETY Act Renewal, 

Application for SAFETY Act 

Developmental Testing and Evaluation 

(DT&E) Designation (DHS Form 10006), 

Application for SAFETY Act 

Designation (DHS Form 10008), 

Application for SAFETY Act 

Certification (DHS Form 10007), 

Application for SAFETY Act Block 

Designation (DHS Form 10005), and 

Application for SAFETY Act Block 

Certification (DHS Form 10004). 

In 2002, The Support Anti-Terrorism 

by Fostering Effective Technologies 

(SAFETY) Act (6 CFR Part 25) was 

enacted as part of the Homeland 

Security Act of 2002, Public Law 107– 

296. The SAFETY Act program 

promotes the development and use of 

anti-terrorism technologies that will 

enhance the protection of the nation and 

provides risk management and litigation 

management protections for sellers of 

Qualified Anti-Terrorism Technology 

(QATT) and others in the supply and 

distribution chain. 

The Department of Homeland 

Security Science & Technology 

Directorate (DHS S&T) currently has 

approval to collect information for the 

implementation of the SAFETY Act 

program until January 31, 2010. With 

this notice, DHS S&T seeks approval to 

renew this information collection for 

continued use after this date. The 

SAFETY Act program requires the 

collection of this information in order to 

evaluate and qualify Anti-Terrorism 

Technologies, based on the economic 

and technical criteria contained in the 

SAFETY Act Final Rule, for protection 

in accordance with the Act, and 

therefore encourage the development 

and deployment of new and innovative 

anti-terrorism products and services. 

This notice and request for comments 

is required by the Paperwork Reduction 

Act of 1995 (Pub. L. 104–13, 44 U.S.C. 

chapter 35). 

DATES: Comments are encouraged and 

will be accepted until August 17, 2009. 

ADDRESSES: Interested persons are 

invited to submit written comments on 

the proposed information collection to 

the Office of Information and Regulatory 

Affairs, Office of Management and 

Budget. Comments should be addressed 

to Desk Officer for the Department of 

Homeland Security, Science & 

Technology Directorate, and sent via 

electronic mail to 

oira_submission@omb.eop.gov or faxed 

to (202) 395–6974. Please include the 

docket number [DHS–2009–0086] in the 

subject line of the message. 

FOR FURTHER INFORMATION CONTACT: 

Michael Bowerbank, 202–254–6895. 

SUPPLEMENTARY INFORMATION: DHS S&T 

provides a secure website, accessible 

through http://www.SAFETYAct.gov, 

through which the public can learn 

about the program, submit applications 

for SAFETY Act protections, submit 

questions to the Office of SAFETY Act 

Implementation (OSAI), and provide 

feedback. The data collection forms 

have standardized the collection of 

information that is both necessary and 

essential for the DHS OSAI.